January 11, 2025 - 19:31

In a recent discussion, Fritz Gilbert, founder and author of The Retirement Manifesto, emphasizes the significance of pursuing curiosity in retirement. Many individuals focus intensely on the financial aspects of retirement, often overlooking the importance of how they will spend their newfound time. Gilbert highlights that a successful retirement is not solely about having sufficient savings; it also involves cultivating a mindset that encourages exploration and personal growth.
Retirement can be a transformative phase, providing opportunities to engage in hobbies, learn new skills, or travel. Gilbert suggests that retirees should prioritize their interests and passions, allowing their curiosity to guide them in this new chapter of life. By doing so, they can discover a renewed sense of purpose and fulfillment. The conversation underscores the need for a balanced approach to retirement planning—one that encompasses both financial security and the pursuit of personal interests, ultimately leading to a more enriching and enjoyable retirement experience.
July 12, 2026 - 04:45
Paramount–Warner Bros. merger could make HBO Max a 'staple'Wall Street is still waiting for the Paramount and Warner Bros. Discovery merger to close, but analysts are already betting on how the combined company will reshape the streaming landscape....
July 11, 2026 - 08:53
$9.5 Billion Focus Financial Network Expands to East Coast with Advisor Jennifer McDonaldMINNEAPOLIS, July 10, 2026 -- Focus Financial Network, a wealth management firm overseeing $9.5 billion in client assets, has expanded its footprint to the East Coast by adding financial advisor...
July 10, 2026 - 21:34
What the housing affordability bill means for buyers and sellersA new bipartisan bill in Congress, the 21st Century ROAD to Housing Act, is aiming to tackle the nation`s affordability crisis head-on. The legislation targets three main pain points: a severe...
July 10, 2026 - 09:43
MindRank Announces $52 Million Series B FinancingMindRank AI Ltd., a clinical-stage biotechnology company based in Hangzhou, China, has announced the completion of a $52 million Series B financing round. The funding was led by a group of...